Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-24-026594
Filing Date
2024-11-12
Accepted
2024-11-12 16:15:05
Documents
1
Period of Report
2024-11-07

Document Format Files

Seq Description Document Type Size
1 form4-11122024_041101.html 4  
1 form4-11122024_041101.xml 4 7153
  Complete submission text file 0001415889-24-026594.txt   8573
Mailing Address 45 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 45 SIDNEY STREET CAMBRIDGE MA 02139 617-374-7580
Blueprint Medicines Corp (Issuer) CIK: 0001597264 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address BLUEPRINT MEDICINES CORP. 215 FIRST STREET, SUITE 340/350 CAMBRIDGE MA 02142
Business Address
Albers Jeffrey W. (Reporting) CIK: 0001638474 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37359 | Film No.: 241448336